Evidence map›Paper›PMID 20102179›Full record

ArticleAnalytical chemistry2010

High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine.

Damon S Anderson, Matthew M Heeney, Udo Roth, Christoph Menzel, Mark D Fleming, Hanno Steen

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Damon S AndersonDepartment of Pathology, Children's Hospital Boston, Boston, Massachusetts 02115, USA.
Matthew M Heeney
Udo Roth
Christoph Menzel
Mark D Fleming
Hanno Steen
Harvard University · US

Funding

Clinical Hematology Research Career Development Program (K12)K12HL087164 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI CANTOR, ALAN B. · 2006 to 2016
$3.9M
Metalloreductases in MedicineR01DK080011 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI FLEMING, MARK D · 2007 to 2010
$1.3M
Pathobiology of the Developing Cardiovascular SystemT32HL076115 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI FLEMING, MARK D · 2005 to 2009
$970k
NHLBI NIH HHS K12 HL087164NHLBI NIH HHS T32 HL076115NIDDK NIH HHS R01 DK080011
6 · The paper itself

Abstract

Levels of the peptide hormone hepcidin negatively correlate with systemic iron status and are increased in disorders in which iron metabolism is secondarily disregulated, such as the anemia of chronic disease. Consequently, the ability to measure hepcidin in the clinical setting may have diagnostic value for a broad range of indications. We describe a novel quantitative matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry assay for hepcidin in human urine which involves (i) direct enrichment from minute volumes (5 microL) of minimally treated urine on the surface of a functionalized chip, (ii) quantification by the use of a stable isotope labeled internal standard, and (iii) analysis by MALDI-TOF. Performance features include a wide linear range (1-1000 nM; LOQ 2.5 nM), high accuracy (90-110% recovery) and precision (intraday CV 12.11%; interday CV 13.21%), and a strong correlation upon interlaboratory cross validation with an existing immunoassay. The assay is simple, accurate, and efficient, and the high-throughput performance features of the assay make large-scale clinical research studies feasible.

Indexed as

High-Throughput Screening AssaysSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAntimicrobial Cationic PeptidesHepcidinsHumansImmunoassayLinear ModelsReproducibility of ResultsUrinalysisAntimicrobial Cationic PeptidesHAMP protein, humanHepcidins

Identifiers

PMID20102179
PMCPMC2830621
OpenAlexW2055406894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.